Untitled-2 Untitled-2 Untitled-2
Accelerating
Healthcare Innovation
1315 Capital invests in exceptional healthcare teams and companies

1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. We target markets where high-quality management teams can rapidly scale platform companies into large and important businesses that positively impact patients, physicians, and the broader healthcare system.

Investment
Leadership

The 1315 Capital investment team combines financial and business development expertise with deep industry knowledge to support the growth of our portfolio companies.

Learn More

OPERATING
TEAMS

1315 Capital employs a unique Operating Team model to navigate diligence, drive decisions, and achieve premium exits.

Learn More

Tangible
ENGAGEMENT

1315 Capital has a deep network that it leverages for management talent, advisors, deal sourcing, diligence, and boards roles.

Learn More

News & Events
Onkos Surgical™ Secures $17.6M in Series B Funding
April 19, 2017
Onkos Surgical™ Partners with PatientIQ to Launch Clinical Registry for Surgical Oncology Patients
March 14, 2017
Ampersand Capital Partners and 1315 Capital Close Transaction to Acquire Genoptix
March 07, 2017
Portfolio

Dermatology company committed to delivering innovative prescription therapies and medical devices to dermatologists.

Oncology diagnostics company that provides oncologists and pathologists with comprehensive testing solutions in hematology and solid tumor molecular profiling.

Cost-containment service company focused on reprocessing single-use medical devices.

Special needs equipment and supply company that serves the pediatric and adult special needs population.

Specialty pharmaceutical company focused on nutraceutical and women’s health products.

Medical device company focused on the orthopedic oncology market.

Generic Levitra - active ingredient: Vardenafil. Presented at dosages of 20, 40 mg, and compatible with the alcohol version. The effect occurs after an average of 30-40 minutes after administration. Read more: